ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) EVP Mark Schneyer sold 5,849 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. Get ACADIA Pharmaceuticals alerts:ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) last issued its earnings results on Tuesday, August 4th. More ACADIA Pharmaceuticals NewsHere are the key news stories impacting ACADIA Pharmaceuticals this week:Positive Sentiment: HC Wainwright raised its long-term earnings outlook. Zacks ACADIA earnings estimate outlookZacks highlighted ACADIA among healthcare companies with strong earnings momentum and said recent estimate revisions could support further near-term gains. Featured ArticlesReceive News & Ratings for ACADIA Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.